PLATINUM-RESISTANT OVARIAN CANCER
Clinical trials for PLATINUM-RESISTANT OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new PLATINUM-RESISTANT OVARIAN CANCER trials appear
Sign up with your email to follow new studies for PLATINUM-RESISTANT OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a common blood pressure pill boost chemo for resistant ovarian cancer?
Disease control Not yet recruitingThis study tests whether adding losartan (a blood pressure medicine) to weekly paclitaxel chemotherapy can shrink tumors in people with ovarian cancer that no longer responds to platinum-based drugs. About 27 adults with advanced ovarian, fallopian tube, or primary peritoneal can…
Matched conditions: PLATINUM-RESISTANT OVARIAN CANCER
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Engineered immune cells take on tough ovarian cancer
Disease control Not yet recruitingThis early-stage trial tests a new treatment called GB-5267, which uses a patient's own immune cells (T cells) that are modified to better find and attack ovarian cancer cells. The study includes 18 adults with platinum-resistant ovarian cancer, meaning their cancer did not respo…
Matched conditions: PLATINUM-RESISTANT OVARIAN CANCER
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 19, 2026 11:59 UTC